Abstract
Introduction The success of the CDK4/6 inhibitor Ibrance (TM) (Palbociclib) as an anticancer agent inspired and directed more efforts toward the disco......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
